Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
SPARC and the Depression and Bipolar Support Alliance surveyed over 6,000 people, revealing treatment gaps, overlooked youth, and the need to center lived experience in bipolar disorder research.
SPARC’s Giving Smarter Guide highlights how philanthropy can accelerate the adoption of precision health by funding tools, data sharing, and infrastructure to make proactive care a reality.
This report examines a decade of global funding for tau-related neurodegenerative disease research, offering insight into progress, gaps, and opportunities for future discovery.
Mental health is an integral part of health and well-being. However, mental health conditions are highly prevalent and largely under-treated.
SPARC and the Rainwater Charitable Foundation have partnered to advance tauopathy research, highlighting how philanthropy can drive collaboration and accelerate new diagnostics and treatments.
Pfizer’s decision to end new drug research for Alzheimer’s and Parkinson’s underscores the urgent need for coordinated investment and innovation to address the growing crisis of neurodegenerative disease.
Lipedema is a painful condition with limited treatment options. This guide highlights the state of research and opportunities for philanthropy to help improve care.
Epilepsy remains underfunded despite high unmet need. SPARC’s Giving Smarter Guide outlines key opportunities for philanthropy to drive progress.
SPARC analyzed the NF1 funding landscape to identify where philanthropy can drive impact. The Giving Smarter Guide helps stakeholders understand the field and make strategic funding decisions.
SPARC partnered with SBFF to understand the landscape of Parkinson’s Disease research and funding, identifying opportunities for future investments.